Knight Therapeutics Inc. (OTCPK:KHTRF) Q4 2024 Earnings Conference Call March 20, 2025 8:30 AM ET
Company Participants
Samira Sakhia – President and Chief Executive Officer
Arvind Utchanah – Chief Financial Officer
Amal Khouri – Chief Business Officer
Conference Call Participants
Michael Freeman – Raymond James
Justin Keywood – Stifel
Doug Miehm – RBC Capital Markets
David Martin – Bloom Burton
Tania Armstrong – Canaccord Genuity
Andre Uddin – Research Capital
Operator
Good morning, ladies and gentlemen. My name is Sylvie, and I will be your conference operator today. Welcome to Knight Therapeutics’ Fourth Quarter 2024 Results Conference Call.
Before turning the call over to Samira Sakhia, President and CEO of Knight, listeners are reminded that portions of today’s discussion may, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. The company considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but cautions that these assumptions regarding the future events, many of which are beyond the control of the company and its subsidiaries, may ultimately prove to be incorrect.
The company disclaims any intentions or obligations to update or revise any forward-looking statements, whether a result of new information, future events, except as required by law. We would also like to remind you that questions during today’s call will be taken from analysts only. Should there be any further questions, please contact Knight’s Investor Relations department via e-mail to [email protected] or via phone at (514) 484-4483. I would like to remind everyone that this call is being recorded today, March 20, 2025.
And now I would like to turn the meeting over to your host, Samira Sakhia. Please go ahead.
Samira Sakhia
Thank you, Sylvie. Good morning, everyone, and welcome to
Credit: Source link
